S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
3 Resilient Blue-Chip Stocks to Buy Now
Stocks sink on new COVID variant; Dow loses 905 points
MarketBeat: Week in Review 11/22 - 11/26
Will flight restrictions help as new virus variant emerges?
Biden sets out oil, gas leasing reform, stops short of ban
Black Friday is back but it's not what it used to be
Ship's master said he spent 50 hours sleepless before crash
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
3 Resilient Blue-Chip Stocks to Buy Now
Stocks sink on new COVID variant; Dow loses 905 points
MarketBeat: Week in Review 11/22 - 11/26
Will flight restrictions help as new virus variant emerges?
Biden sets out oil, gas leasing reform, stops short of ban
Black Friday is back but it's not what it used to be
Ship's master said he spent 50 hours sleepless before crash
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
3 Resilient Blue-Chip Stocks to Buy Now
Stocks sink on new COVID variant; Dow loses 905 points
MarketBeat: Week in Review 11/22 - 11/26
Will flight restrictions help as new virus variant emerges?
Biden sets out oil, gas leasing reform, stops short of ban
Black Friday is back but it's not what it used to be
Ship's master said he spent 50 hours sleepless before crash
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
3 Resilient Blue-Chip Stocks to Buy Now
Stocks sink on new COVID variant; Dow loses 905 points
MarketBeat: Week in Review 11/22 - 11/26
Will flight restrictions help as new virus variant emerges?
Biden sets out oil, gas leasing reform, stops short of ban
Black Friday is back but it's not what it used to be
Ship's master said he spent 50 hours sleepless before crash
ASX:NSB

NeuroScientific Biopharmaceuticals Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Receive NSB News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroScientific Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.


About NeuroScientific Biopharmaceuticals

NeuroScientific Biopharmaceuticals Limited develops diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies. The company's lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Cottesloe, Australia.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
ASX:NSB
Previous Symbol
CUSIP
N/A
CIK
N/A
Web
www.neuroscientific.com
Phone
61 8 6382 1800
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
$958.77 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.10 per share
Price / Book
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
64.58
Quick Ratio
63.61

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable

MarketRank™

Overall MarketRank™

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












NeuroScientific Biopharmaceuticals (ASX:NSB) Frequently Asked Questions

Who are NeuroScientific Biopharmaceuticals' key executives?

NeuroScientific Biopharmaceuticals' management team includes the following people:
  • Mr. Matthew Liddelow B.Sc., CEO, MD & Director
  • Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A., CFO & Company Sec.
  • Dr. Anton Uvarov Ph.D., BioChem, MBA, MedGen, CSO & Exec. Director
  • Dr. Alexandra Heaton Ph.D., Director of Operations

What is NeuroScientific Biopharmaceuticals' stock symbol?

NeuroScientific Biopharmaceuticals trades on the ASX under the ticker symbol "NSB."

How much money does NeuroScientific Biopharmaceuticals make?

NeuroScientific Biopharmaceuticals has a market capitalization of $0.00 and generates $958.77 thousand in revenue each year.

What is NeuroScientific Biopharmaceuticals' official website?

The official website for NeuroScientific Biopharmaceuticals is www.neuroscientific.com.

How can I contact NeuroScientific Biopharmaceuticals?

The company can be reached via phone at 61 8 6382 1800.


This page was last updated on 11/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.